前收市價 | 85.16 |
開市 | 85.34 |
買盤 | 84.94 x 200 |
賣出價 | 85.00 x 200 |
今日波幅 | 84.62 - 86.12 |
52 週波幅 | 62.35 - 94.50 |
成交量 | |
平均成交量 | 3,565,220 |
市值 | 38.774B |
Beta 值 (5 年,每月) | 無 |
市盈率 (最近 12 個月) | 27.95 |
每股盈利 (最近 12 個月) | 3.04 |
業績公佈日 | 無 |
遠期股息及收益率 | 0.12 (0.14%) |
除息日 | 2024年4月18日 |
1 年預測目標價 | 95.71 |
Retail healthcare is a growing area of interest for many companies, as healthcare moves into the home and both retailers and traditional companies eye a piece of the nearly $4 trillion health industry pie.
GE Healthcare's potential windfall from Leqembi approval is being hampered by CMS coverage of PET scans.
Allurion went public this week, and thinks the current focus on obesity can boost its own platform and products.